期刊文献+

保肝汤配合硫普罗宁片治疗酒精性肝病90例 被引量:4

Integrated Traditional and Western Medicine of 90 Alcoholic Liver Disease
下载PDF
导出
摘要 [目的]观察中西医结合治疗酒精性肝病的疗效及安全性。[方法]将180例患者按就诊单双号随机分为两组,中西医结合治疗组使用中药制剂保肝汤联合硫普罗宁片100mg,3次/d;西药对照组使用硫普罗宁片100mg,3次/d,治疗8周进行疗效判定。[结果]4周后治疗组总有效率为94.4%,对照组总有效率为66.6%,治疗组疗效优于对照组(P(0.05)。不良反应发生率治疗组为5.6%,低于对照组20%(P<0.05)。[结论]中西医结合治疗酒精性肝病疗效好,副作用少。 [Objective] To observe there is a combination of the effect of alcohol to treat liver and security.[Method] 180 cases of alcohol to people in the liver single and double the number of randomly divided into two groups,there is a combination therapy groups,and western medicine;there is a combination of the treatment of using chinese medicines for the liver of sulphur for the union thus luo ning table 100mg,three times/d;Course for 8 weeks,two groups of reaction.[Results] The curative and treatment groups:4 weeks for the efficient 94.4%,the total availability for 66.6%,there is a combination of the curative treatment beats western medicine(P﹤0.05).adverse reaction rate of 5.6 % for treatment,the less than 20%(P﹤0.05):combination therapy.[Conclusion]Sexual liver alcohol,adverse effect.
作者 康汝光 刘岩
出处 《实用中医内科杂志》 2011年第6期78-79,共2页 Journal of Practical Traditional Chinese Internal Medicine
关键词 酒精性肝病 保肝汤 硫普罗宁片 Alcoholic liver disease Protection liver soup Tiopronin table
  • 相关文献

参考文献3

二级参考文献20

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Lok AS,McMahon B J; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.
  • 3Sanyal AJ.American Gastroenterological Association technical review on nonalcoholic fatty liver disease.Gastroenterology,2002,123:1705-1725.
  • 4Graif M,Yanuka M,Baraz M,et al.Quantitative estimation of attenuation in ultrasound video images:correlation with histology in diffuse liver disease.Invest Radiol,2000,35:319-324.
  • 5Ataseven H,Yildrim MH,Yalniz M,et al.Correlation between computerized tomographic findings and histopathologic grade/stage in non-alcoholic steatohepatitis.J Hepatol,2003,38(Suppl 2):A4177.
  • 6Farrell GC,George J,Pauline de la M.Hall,et al,eds.Fatty liver diseas:NASH and related disorders.Oxford:Blackwell Publishing,2005.159-207.
  • 7McCullough AJ,O'Connor JF.Alcoholic liver disease:proposed recommendations for the American College of Gastroenterology.Am J Gastroenterol,1998,93:2022-2036.
  • 8Stickel F,Hoehn B,Schuppan D,et al.Review article:Nutritional therapy in alcoholic liver disease.Aliment Pharmacol Ther,2003,18:357-373.
  • 9Mathurin P,Mendenhall CL,Carithers RLJr,et al.Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH):individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.J Hepatol,2002,36:480-487.
  • 10Imperiale TF,O'Connor JB,McCullough AJ.Corticosteroids are effective in patients with severe alcoholic hepatitis.Am J Gastroenterol,1999,94:3066-3068.

共引文献434

同被引文献60

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部